Boysen v. Peacehealth

CourtDistrict Court, D. Oregon
DecidedAugust 19, 2024
Docket6:23-cv-01229
StatusUnknown

This text of Boysen v. Peacehealth (Boysen v. Peacehealth) is published on Counsel Stack Legal Research, covering District Court, D. Oregon primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Boysen v. Peacehealth, (D. Or. 2024).

Opinion

IN THE UNITED STATES DISTRICT COURT

FOR THE DISTRICT OF OREGON

EUGENE DIVISION

SARA BOYSEN, et al.,

Plaintiffs, Case No. 6:23-cv-01229-AA v. OPINION & ORDER

PEACEHEALTH, et al.,

Defendants. _______________________________________

This matter comes before the Court on PeaceHealth, Liz Dunne, Doug Koekkoek, and Todd Salnas’s (collectively “PeaceHealth” or “PeaceHealth Defendants”) Motion to Dismiss, ECF No. 25, and on (former) Oregon State Governor Kate Brown and (former) Director of Oregon Health Authority Patrick Allen’s (collectively “State Defendants”) Motion to Dismiss. ECF No. 12. State Defendants also move to join the PeaceHealth motion to dismiss. ECF No. 26. For the reasons explained, the Motion to Join, ECF No. 26 is GRANTED. PeaceHealth and State Defendants’ Motions to Dismiss, ECF Nos. 12, 25, are GRANTED. This case is DISMISSED with prejudice. BACKGROUND

I. Factual Background All background is drawn from the allegations in the Complaint, along with judicially noticed facts pursuant to Federal Rule of Evidence 201(b): “[t]he court may judicially notice a fact that is not subject to reasonable dispute because it: (1) is generally known within the trial court's territorial jurisdiction; or (2) can be accurately and readily determined from sources whose accuracy cannot be reasonably questioned.”

The global tribulation caused by the Covid-19 pandemic, which broke out in 2020, is now well-known. This case, filed in August 2023, arises from Defendants’ mandates that healthcare workers be vaccinated against Covid-19 or obtain a medical or religious exemption. Compl. ¶¶ 19, 230. Plaintiffs are former healthcare workers suing their employer, PeaceHealth, a licensed general hospital provider, and three PeaceHealth executives: Liz Dunne, Todd Salnas, and Doug Koekkoek. Compl. ¶¶

32-35, 231. Plaintiffs also name as Defendants then-acting Oregon governor Kate Brown and Patrick Allen, former director of the Oregon Health Authority, for issuing orders mandating vaccination. Id. ¶¶ 35.1-35.2. The crux of Plaintiffs’ claim is that the “Pfizer-BioNTech COVID-19 Vaccine” (“Pfizer Vaccine”) is not a vaccine. Rather, it is an investigational medical product legally distinct from a vaccine. Id. ¶¶ 37, 287. Essentially, Plaintiffs maintain that the Pfizer Vaccine was first made available by the federal government through the emergency authorization process, rather than through a commercial license to pharmaceutical companies to market it for its intended use, and therefore, has no

indication to treat, cure, or prevent any disease. Id. ¶¶ 81, 88, 94, 259, 489, 533. According to Plaintiffs, because the Pfizer Vaccine is not really a vaccine, but instead medical treatment, Plaintiffs have a federally secured right to refuse it without losing their employment benefits. Id. ¶ 37. Plaintiffs allege that, on August 5, 2021, “[d]uring the height of the pandemic, when hospitalization rates soared, and SARS-CoV-2 variants abounded,” PeaceHealth implemented a policy requiring its caregivers to be fully vaccinated

against COVID-19 or have an approved medical or religious exception from the vaccine. Id. ¶¶ 21, 262. Later, on August 25, 2021, the Oregon Health Authority (“OHA”) issued a rule implementing similar statewide orders requiring that all health state licensed healthcare workers either receive a Covid-19 vaccine or obtain an approved medical or religious exemption. Id. ¶ 261; Ex. D. When Plaintiffs refused to receive a vaccination, obtain a medical exception, or

provide a religious exception, PeaceHealth presumably terminated Plaintiffs. Id. ¶¶ 31.1-31.12. Plaintiffs contend that all Defendants violated their constitutional and international treaty rights, federal statutory rights, and that Defendants breached a contract and committed various state torts in connection with their “unlawful, malicious, unequal and contractually violative COVID-19 investigational drug mandate[s].” Id. at 4. Both State Defendants and PeaceHealth move to dismiss Plaintiffs’ Complaint in its entirety. II. Emergency Use Authorization and the Pfizer Vaccine

The Emergency Use Authorization (“EUA”) authority allows the Food and Drug Administration (“FDA”) to help strengthen the nation’s public health protections against threats including infectious diseases, by facilitating the availability and use of medical countermeasures needed during public health emergencies. Compl. Ex. C at 11.1 Accordingly, the Health and Human Services (“HHS”) Secretary declared that circumstances exist justifying the authorization of emergency use of drugs and biological products during the COVID-19 pandemic,

pursuant to section 564 of the [Food, Drug, and Cosmetic] Act, effective March 27, 2020. Id.2 As described in text in official government websites, hyperlinked in attachments to Plaintiffs’ Complaint, for an EUA to be issued for a vaccine, the manufacturer of the vaccine must undergo a rigorous development process that

1 The Court incorporates by reference, set forth in Exhibit C attached to Plaintiffs’ Complaint, hyperlinks to the FDA’s official government website: “Food and Drug Administration: Emergency Use Authorization – About Emergency Use Authorizations (EUAs),” available at https://www.fda.gov/emergency-preparedness- and-response/mcm-legal-regulatory-and-policy-framework/emergency-use- authorization).

2 See “Coronavirus Disease 2019 (COVID-19) EUA Information, “Detailed Information for all COVID-19 EUAs, including authorizations and fact sheets, COVID-19 EUAs for Vaccines,” available at https://www.fda.gov/emergency- preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency- use-authorization#vaccines. includes tens of thousands of study participants to generate non-clinical, clinical, and manufacturing information needed by FDA for the agency to determine whether the known and potential benefits outweigh the known and potential risks of a vaccine for

the prevention of COVID-19. Id.3 Ultimately, after Pfizer-BioNTech received Emergency Use Authorization for its Covid-19 vaccine in December 2020. See Compl. ¶ 108 n. 25 (citing ACIP, Morbidity and Mortality Weekly Report, “Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥ 16 Years: Recommendations of the Advisory Committee on Immunization Practices – United States, September 2021”, Vol.70, No.38, at 1,

available at https://stacks.cdc.gov/view/cdc/109943). The CDC Advisory Committee on Immunization Practices (“ACIP”) reported high rates of efficacy of the Pfizer Vaccine “in preventing symptomatic, laboratory- confirmed Covid-19.” Id. at 2. In fact, the ACIP report refers to the Pfizer Vaccine as a “vaccine” and discusses its success and efficacy for immunization during the eight months it was offered under the EUA. Id. at 1-5. The report states that evidence supports the use of Pfizer Vaccine, “and that the desirable effects of disease

prevention via vaccination with the [Pfizer] vaccine” are large and outweigh the potential harms. Id. at 4. As of September 22, 2021, the report then announced that the Pfizer Vaccine had been fully approved: In summary, after 8 months of use under an FDA EUA and ACIP interim recommendation, the Pfizer-BioNTech COVID-19 vaccine,

3 See id., “Emergency Use Authorizations for Vaccines Explained” available at https://www.fda.gov/vaccines-blood-biologics/vaccines/emergency-use-authorization- vaccines-explained. Comirnaty, now has full FDA approval and is recommended by ACIP for use in persons aged ≥16 years in the United States. Comirnaty has the same formulation and can be used interchangeably with the Pfizer-BioNTech COVID-19 vaccine used under EUA without presenting any safety or effectiveness concerns.

Id. See also Johnson v. Brown, 567 F. Supp.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Jacobson v. Massachusetts
197 U.S. 11 (Supreme Court, 1905)
Ex Parte Young
209 U.S. 123 (Supreme Court, 1908)
Ford Motor Co. v. Department of Treasury
323 U.S. 459 (Supreme Court, 1945)
Jackson v. Metropolitan Edison Co.
419 U.S. 345 (Supreme Court, 1974)
Parratt v. Taylor
451 U.S. 527 (Supreme Court, 1981)
Blum v. Yaretsky
457 U.S. 991 (Supreme Court, 1982)
Daniels v. Williams
474 U.S. 327 (Supreme Court, 1986)
South Dakota v. Dole
483 U.S. 203 (Supreme Court, 1987)
Will v. Michigan Department of State Police
491 U.S. 58 (Supreme Court, 1989)
Sosa v. Alvarez-Machain
542 U.S. 692 (Supreme Court, 2004)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Pearson v. Callahan
555 U.S. 223 (Supreme Court, 2009)
Koontz v. St. Johns River Water Management Dist.
133 S. Ct. 2586 (Supreme Court, 2013)
Johnson v. Riverside Healthcare System, LP
534 F.3d 1116 (Ninth Circuit, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
Boysen v. Peacehealth, Counsel Stack Legal Research, https://law.counselstack.com/opinion/boysen-v-peacehealth-ord-2024.